Skip to main content
SpringerLink
Log in

Magnetic resonance and fluorescence based molecular imaging technologies

  • Chapter
Imaging in Drug Discovery and Early Clinical Trials

Part of the book series: Progress in Drug Research ((PDR,volume 62))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Weissleder R, Mahmood U (2001) Molecular imaging. Radiology 219: 316–333

    PubMed  CAS  Google Scholar 

  2. Ruff J, Wiesmann F, Hiller KH, Voll S, von Kienlin M, Bauer WR, Rommel E, Neubauer S, Haase A (1998) Magnetic resonance microimaging for noninvasive quantification of myocardial function and mass in the mouse. Magn Reson Med 40: 43–48

    PubMed  CAS  Google Scholar 

  3. Funovics MA, Weissleder R, Mahmood U (2004) Catheter-based in vivo imaging of enzyme activity and gene expression: feasibility study in mice. Radiology 231: 659–666

    PubMed  Google Scholar 

  4. Mahmood U, Tung CH, Bogdanov A Jr., Weissleder R (1999) Near-infrared optical imaging of protease activity for tumor detection. Radiology 213: 866–870

    PubMed  CAS  Google Scholar 

  5. Weissleder R (2002) Scaling down imaging: molecular mapping of cancer in mice. Nat Rev Cancer 2: 11–18

    Article  PubMed  CAS  Google Scholar 

  6. Rudin M, Weissleder R (2003) Molecular imaging in drug discovery and development. Nat Rev Drug Discov 2: 123–131

    Article  PubMed  CAS  Google Scholar 

  7. Josephson L, Kircher MF, Mahmood U, Tang Y, Weissleder R (2002) Near-infrared fluorescent nanoparticles as combined MR/optical imaging probes. Bioconjug Chem 13: 554–560

    Article  PubMed  CAS  Google Scholar 

  8. Kircher MF, Mahmood U, King RS, Weissleder R, Josephson L (2003) A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation. Cancer Res 63: 8122–8125

    PubMed  CAS  Google Scholar 

  9. Weissleder R, Ntziachristos V (2003) Shedding light onto live molecular targets. Nat Med 9: 123–128

    Article  PubMed  CAS  Google Scholar 

  10. Rudin M, Beckmann N, Porszasz R, Reese T, Bochelen D, Sauter A (1999) In vivo magnetic resonance methods in pharmaceutical research: current status and perspectives. NMR Biomed 12: 69–97

    PubMed  CAS  Google Scholar 

  11. Beckmann N, Mueggler T, Allegrini PR, Laurent D, Rudin M (2001) From anatomy to the target: contributions of magnetic resonance imaging to preclinical pharmaceutical research. Anat Rec 265: 85–100

    Article  PubMed  CAS  Google Scholar 

  12. Jain RK, Munn LL, Fukumura D (2002) Dissecting tumour pathophysiology using intravital microscopy. Nat Rev Cancer 2: 266–276

    Article  PubMed  CAS  Google Scholar 

  13. Phelps ME (2000) Inaugural article: positron emission tomography provides molecular imaging of biological processes. Proc Natl Acad Sci USA 97: 9226–9233

    Article  PubMed  CAS  Google Scholar 

  14. Fischman AJ, Alpert NM, Rubin RH (2002) Pharmacokinetic imaging: a noninvasive method for determining drug distribution and action. Clin Pharmacokinet 41: 581–602

    PubMed  CAS  Google Scholar 

  15. Tjuvajev JG, Stockhammer G, Desai R, Uehara H, Watanabe K, Gansbacher B, Blasberg RG (1995) Imaging the expression of transfected genes in vivo. Cancer Res 55: 6126–6132

    PubMed  CAS  Google Scholar 

  16. Gambhir SS, Barrio JR, Phelps ME, Iyer M, Namavari M, Satyamurthy N, Wu L, Green LA, Bauer E, MacLaren DC et al. (1999) Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography. Proc Natl Acad Sci USA 96: 2333–2338

    Article  PubMed  CAS  Google Scholar 

  17. Moore A, Josephson L, Bhorade RM, Basilion JP, Weissleder R (2001) Human transferrin receptor gene as a marker gene for MR imaging. Radiology 221: 244–250

    PubMed  CAS  Google Scholar 

  18. Tung CH, Bredow S, Mahmood U, Weissleder R (1999) Preparation of a cathepsin D sensitive near-infrared fluorescence probe for imaging. Bioconjug Chem 10: 892–896

    Article  PubMed  CAS  Google Scholar 

  19. Weissleder R, Tung CH, Mahmood U, Bogdanov A Jr (1999) In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat Biotechnol 17: 375–378

    Article  PubMed  CAS  Google Scholar 

  20. Perez JM, Josephson L, O’Loughlin T, Hogemann D, Weissleder R (2002) Magnetic relaxation switches capable of sensing molecular interactions. Nat Biotechnol 20: 816–820

    PubMed  CAS  Google Scholar 

  21. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, Klocke FJ, Bonow RO, Judd RM (2000) The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 343: 1445–1453

    Article  PubMed  CAS  Google Scholar 

  22. Earls JP, Ho VB, Foo TK, Castillo E, Flamm SD (2002) Cardiac MRI: recent progress and continued challenges. J Magn Reson Imaging 16: 111–127

    Article  PubMed  Google Scholar 

  23. Neubauer S, Beer M, Landschutz W, Sandstede J, Seyfarth T, Lipke C, Kostler H, Pabst TKenn W, Meininger M, von Kienlin M et al (2000) Absolute quantification of high energy phosphate metabolites in normal, hypertrophied and failing human myocardium. Magma 11: 73–74

    PubMed  CAS  Google Scholar 

  24. Bjerner T, Johansson L, Ericsson A, Wikstrom G, Hemmingsson A, Ahlstrom H (2001) First-pass myocardial perfusion MR imaging with outer-volume suppression and the intravascular contrast agent NC100150 injection: preliminary results in eight patients. Radiology 221: 822–826

    PubMed  CAS  Google Scholar 

  25. Stillman AE, Wilke N, Jerosch-Herold M (1997) Use of an intravascular T1 contrast agent to improve MR cine myocardial-blood pool definition in man. J Magn Reson Imaging 7: 765–767

    PubMed  CAS  Google Scholar 

  26. Paetsch I, Thiele H, Schnackenburg B, Bornstedt A, Muller-York A, Schwab J, Fleck E, Nagel E (2003) Improved functional cardiac MR imaging using the intravascular contrast agent CLARISCAN. Int J Cardiovasc Imaging 19: 337–343

    PubMed  CAS  Google Scholar 

  27. Harisinghani MG, Barentsz J, Hahn PF, Deserno WM, Tabatabaei S, van de Kaa CH, de la Rosette J, Weissleder R (2003) Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 348: 2491–2419

    Article  PubMed  Google Scholar 

  28. Lauffer RB (1990) Magnetic resonance contrast media: principles and progress. Magn Reson Q 6: 65–84

    PubMed  CAS  Google Scholar 

  29. Chapon C, Franconi F, Lemaire L, Marescaux L, Legras P, Saint-Andre JP, Denizot B, Le Jeune JJ (2003) High field magnetic resonance imaging evaluation of superparamagnetic iron oxide nanoparticles in a permanent rat myocardial infarction. Investigative Radiology 38: 141–146

    Article  PubMed  CAS  Google Scholar 

  30. Lanza GM, Lorenz CH, Fischer SE, Scott MJ, Cacheris WP, Kaufmann RJ, Gaffney PJ, Wickline SA (1998) Enhanced detection of thrombi with a novel fibrin-targeted magnetic resonance imaging agent. Acad Radiol 5,Suppl 1: S173–S176; discussion S183-S184

    PubMed  Google Scholar 

  31. Winter PM, Caruthers SD, Yu X, Song SK, Chen J, Miller B, Bulte JW, Robertson JD, Gaffney PJ, Wickline SA, Lanza GM (2003) Improved molecular imaging contrast agent for detection of human thrombus. Magn Reson Med 50: 411–416

    Article  PubMed  CAS  Google Scholar 

  32. Botnar RM, Perez AS, Witte S, Wiethoff AJ, Laredo J, Hamilton J, Quist W, Parsons EC Jr, Vaidya A, Kolodziej A et al. (2004) In vivo molecular imaging of acute and subacute thrombosis using a fibrin-binding magnetic resonance imaging contrast agent. Circulation 109: 2023–2029

    Article  PubMed  CAS  Google Scholar 

  33. Morawski AM, Winter PM, Crowder KC, Caruthers SD, Fuhrhop RW, Scott MJ, Robertson JD, Abendschein DR, Lanza GM, Wickline SA (2004) Targeted nanoparticles for quantitative imaging of sparse molecular epitopes with MRI. Magn Reson Med 51: 480–486

    Article  PubMed  CAS  Google Scholar 

  34. Weissleder R, Liver MR (1994) imaging with iron oxides: toward consensus and clinical practice. Radiology 193: 593–595

    PubMed  CAS  Google Scholar 

  35. Johansson LO, Bjerner T, Bjornerud A, Ahlstrom H, Tarlo KS, Lorenz CH (2002) Utility of NC100150 injection in cardiac MRI. Acad Radiol 9,Suppl 1: S79–S81

    PubMed  Google Scholar 

  36. Weissleder R, Stark DD, Engelstad BL, Bacon BR, Compton CC, White DL, Jacobs P, Lewis J (1989) Superparamagnetic iron oxide: pharmacokinetics and toxicity. AJR Am J Roentgenol 152: 167–173

    PubMed  CAS  Google Scholar 

  37. Josephson L, Groman E, Weissleder R (1991) Contrast agents for magnetic resonance imaging of the liver. Targeted Diagn Ther 4: 163–187

    PubMed  CAS  Google Scholar 

  38. Shen T, Weissleder R, Papisov M, Bogdanov A Jr., Brady TJ (1993) Monocrystalline iron oxide nanocompounds (MION): physicochemical properties. Magn Reson Med 29: 599–604

    PubMed  CAS  Google Scholar 

  39. Bunce, N.H. et al. (2001) Improved cine cardiovascular magnetic resonance using Clariscan (NC100150 injection). J Cardiovasc Magn Reson 3: 303–310

    PubMed  CAS  Google Scholar 

  40. Weissleder R, Lee AS, Khaw BA, Shen T, Brady TJ (1992) Antimyosin-labeled monocrystalline iron oxide allows detection of myocardial infarct: MR antibody imaging. Radiology 182: 381–385

    PubMed  CAS  Google Scholar 

  41. Schellenberger EA, Reynolds F, Weissleder R, Josephson L (2004) Surface-functionalized nanoparticle library yields probes for apoptotic cells. Chembiochem 5: 275–279

    PubMed  CAS  Google Scholar 

  42. Lewin M, Carlesso N, Tung CH, Tang XW, Cory D, Scadden DT, Weissleder R (2000) Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Biotechnol 18: 410–414

    PubMed  CAS  Google Scholar 

  43. Wunderbaldinger P, Josephson L, Weissleder R (2002) Tat peptide directs enhanced clearance and hepatic permeability of magnetic nanoparticles. Bioconjug Chem 13: 264–268

    Article  PubMed  CAS  Google Scholar 

  44. Hogemann D, Ntziachristos V, Josephson L, Weissleder R (2002) High throughput magnetic resonance imaging for evaluating targeted nanoparticle probes. Bioconjug Chem 13: 116–121

    Article  PubMed  Google Scholar 

  45. Louie AY, Huber MM, Ahrens ET, Rothbacher U, Moats R, Jacobs RE, Fraser SE, Meade TJ (2000) In vivo visualization of gene expression using magnetic resonance imaging. Nat Biotechnol 18: 321–325

    PubMed  CAS  Google Scholar 

  46. Bogdanov A Jr., Matuszewski L, Bremer C, Petrovsky A, Weissleder R (2002) Oligomerization of paramagnetic substrates result in signal amplification and can be used for MR imaging of molecular targets. Mol Imaging 1: 16–23

    PubMed  CAS  Google Scholar 

  47. Chen JW, Pham W, Weissleder R, Bogdanov A Jr (2004) Human myeloperoxidase: a potential target for molecular MR imaging in atherosclerosis. Magn Reson Med 52: 1021–1028

    PubMed  CAS  Google Scholar 

  48. Capdeville R, Buchdunger E, Zimmermann J, Matter A (2002) Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug. Nat Rev Drug Discov 1: 493–502

    Article  PubMed  CAS  Google Scholar 

  49. Perez JM, Josephson L, Weissleder R (2004) Use of magnetic nanoparticles as nanosensors to probe for molecular interactions. Chembiochem 5: 261–264

    Article  PubMed  CAS  Google Scholar 

  50. Perez JM, O’Loughin T, Simeone FJ, Weissleder R, Josephson L (2002) DNA-based magnetic nanoparticle assembly acts as a magnetic relaxation nanoswitch allowing screening of DNA-cleaving agents. J Am Chem Soc 124: 2856–2857

    Article  PubMed  CAS  Google Scholar 

  51. Perez JM, Simeone FJ, Saeki Y, Josephson L, Weissleder R (2003) Viral-induced self-assembly of magnetic nanoparticles allows the detection of viral particles in biological media. J Am Chem Soc 125: 10192–10193

    Article  PubMed  CAS  Google Scholar 

  52. Tsourkas A, Hofstetter O, Hofstetter H, Weissleder R, Josephson L (2004) Magnetic relaxation switch immunosensors detect enantiomeric impurities. Angew Chem Int Ed Engl 43: 2395–2399

    Article  PubMed  CAS  Google Scholar 

  53. Tung CH, Weissleder R (2003) Arginine containing peptides as delivery vectors. Adv Drug Deliv Rev 55: 281–294

    Article  PubMed  CAS  Google Scholar 

  54. Ntziachristos V, Weissleder R (2002) Charge-coupled-device based scanner for tomography of fluorescent near-infrared probes in turbid media. Med Phys 29: 803–809

    Article  PubMed  Google Scholar 

  55. Ntziachristos V, Bremer C, Weissleder R (2003) Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging. Eur Radiol 13: 195–208

    PubMed  Google Scholar 

  56. Tromberg BJ, Shah N, Lanning R, Cerussi A, Espinoza J, Pham T, Svaasand L, Butler J (2000) Non-invasive in vivo characterization of breast tumors using photon migration spectroscopy. Neoplasia 2: 26–40

    Article  PubMed  CAS  Google Scholar 

  57. Chance B (2001) Near-infrared (NIR) optical spectroscopy characterizes breast tissue hormonal and age status. Acad Radiol 8: 209–210

    Article  PubMed  CAS  Google Scholar 

  58. Hanlon EB, Manoharan R, Koo TW, Shafer KE, Motz JT, Fitzmaurice M, Kramer JR, Itzkan I, Dasari RR, Feld MS (2000) Prospects for in vivo Raman spectroscopy. Phys Med Biol 45: R1–59

    Article  PubMed  CAS  Google Scholar 

  59. Brown EB (2001) In vivo measurement of gene expression, angiogenesis and physiological function in tumors using multiphoton laser scanning microscopy. Nat Med 7: 864–868

    PubMed  CAS  Google Scholar 

  60. Lin Y, Weissleder R, Tung CH (2002) Novel near-infrared cyanine fluorochromes: synthesis, properties, and bioconjugation. Bioconjug Chem 13: 605–610

    Article  PubMed  Google Scholar 

  61. Lin Y, Weissleder R, Tung CH (2003) Synthesis and properties of sulfhydryl-reactive near-infrared cyanine fluorochromes for fluorescence imaging. Mol Imaging 2: 87–92

    Article  PubMed  CAS  Google Scholar 

  62. Ntziachristos V, Tung CH, Bremer C, Weissleder R (2002) Fluorescence molecular tomography resolves protease activity in vivo. Nat Med 8: 757–760

    Article  PubMed  CAS  Google Scholar 

  63. Bremer C, Tung CH, Weissleder R (2001) In vivo molecular target assessment of matrix metalloproteinase inhibition. Nat Med 7: 743–748

    Article  PubMed  CAS  Google Scholar 

  64. Marten K, Bremer C, Khazaie K, Sameni M, Sloane B, Tung CH, Weissleder R (2002) Detection of dysplastic intestinal adenomas using enzyme-sensing molecular beacons in mice. Gastroenterology 122: 406–414

    Article  PubMed  Google Scholar 

  65. Ito S, Muguruma N, Kusaka Y, Tadatsu M, Inayama K, Musashi Y, Yano M, Bando T, Honda H, Shimizu I et al. (2001) Detection of human gastric cancer in resected specimens using a novel infrared fluorescent anti-human carcinoembryonic antigen antibody with an infrared fluorescence endoscope in vitro. Endoscopy 33: 849–853

    Article  PubMed  CAS  Google Scholar 

  66. Funovics MA, Alencar H, Su HS, Khazaie K, Weissleder R, Mahmood U (2003) Miniaturized multichannel near infrared endoscope for mouse imaging. Mol Imaging 2: 350–357

    Article  PubMed  Google Scholar 

  67. Zonios G, Bykowski J, Kollias N (2001) Skin melanin, hemoglobin, and light scattering properties can be quantitatively assessed in vivo using diffuse reflectance spectroscopy. J Invest Dermatol 117: 1452–1457

    Article  PubMed  CAS  Google Scholar 

  68. Kuroiwa T, Kajimoto Y, Ohta T (2001) Development and clinical application of near-infrared surgical microscope: preliminary report. Minim Invasive Neurosurg 44: 240–242

    PubMed  CAS  Google Scholar 

  69. Graves EE, Ripoll J, Weissleder R, Ntziachristos V (2003) A submillimeter resolution fluorescence molecular imaging system for small animal imaging. Med Phys 30: 901–911

    Article  PubMed  CAS  Google Scholar 

  70. Graves EE, Culver JP, Ripoll J, Weissleder R, Ntziachristos V (2004) Singular-value analysis and optimization of experimental parameters in fluorescence molecular tomography. J Opt Soc Am A Opt Image Sci Vis 21: 231–241

    PubMed  CAS  Google Scholar 

  71. Becker A, Hessenius C, Licha K, Ebert B, Sukowski U, Semmler W, Wiedenmann B, Grotzinger C (2001) Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands. Nat Biotechnol 19: 327–331

    Article  PubMed  CAS  Google Scholar 

  72. Kelly K, Alencar H, Funovics M, Mahmood U, Weissleder R (2004) Detection of invasive colon cancer using a novel, targeted, library-derived fluorescent peptide. Cancer Res 64: 6247–6251

    Article  PubMed  CAS  Google Scholar 

  73. Bremer C, Bredow S, Mahmood U, Weissleder R, Tung CH (2001) Optical imaging of matrix metalloproteinase-2 activity in tumors: feasibility study in a mouse model. Radiology 221: 523–529

    PubMed  CAS  Google Scholar 

  74. Bremer C, Tung CH, Bogdanov A Jr., Weissleder R (2002) Imaging of differential protease expression in breast cancers for detection of aggressive tumor phenotypes. Radiology 222: 814–818

    PubMed  Google Scholar 

  75. Dubertret B, Skourides P, Norris DJ, Noireaux V, Brivanlou AH, Libchaber A (2002) In vivo imaging of quantum dots encapsulated in phospholipid micelles. Science 298: 1759–1762

    Article  PubMed  CAS  Google Scholar 

  76. Jaiswal JK, Simon SM (2004) Potentials and pitfalls of fluorescent quantum dots for biological imaging. Trends Cell Biol 14: 497–504

    Article  PubMed  CAS  Google Scholar 

  77. Flacke S, Fischer S, Scott MJ, Fuhrhop RJ, Allen JS, McLean M, Winter P, Sicard GA, Gaffney PJ, Wickline SA, Lanza GM (2001) Novel MRI contrast agent for molecular imaging of fibrin: implications for detecting vulnerable plaques. Circulation 104: 1280–1285

    PubMed  CAS  Google Scholar 

  78. Jaffer FA, Tung CH, Wykrzykowska JJ, Ho NH, Houng AK, Reed GL, Weissleder R (2004) Molecular imaging of factor XIIIa activity in thrombosis using a novel, near-infrared fluorescent contrast agent that covalently links to thrombi. Circulation 110: 170–176

    Article  PubMed  CAS  Google Scholar 

  79. Jaffer FA, Tung CH, Gerszten RE, Weissleder R (2002) In vivo imaging of thrombin activity in experimental thrombi with thrombin-sensitive near-infrared molecular probe. Arterioscler Thromb Vasc Biol 22: 1929–1935

    PubMed  CAS  Google Scholar 

  80. Kang HW, Josephson L, Petrovsky A, Weissleder R, Bogdanov A Jr (2002) Magnetic resonance imaging of inducible E-selectin expression in human endothelial cell culture. Bioconjugate Chemistry 13: 122–127

    Article  PubMed  CAS  Google Scholar 

  81. Chen J, Tung CH, Mahmood U, Ntziachristos V, Gyurko R, Fishman MC, Huang PL, Weissleder R (2002) In vivo imaging of proteolytic activity in atherosclerosis. Circulation 105: 2766–2771

    PubMed  Google Scholar 

  82. Winter PM, Morawski AM, Caruthers SD, Fuhrhop RW, Zhang H, Williams TA, Allen JS, Lacy EK, Robertson JD, Lanza GM, Wickline SA (2003) Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles. Circulation 108: 2270–2274

    Article  PubMed  CAS  Google Scholar 

  83. Sipkins DA, Cheresh DA, Kazemi MR, Nevin LM, Bednarski MD, Li KC (1998) Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging. Nat Med 4: 623–626

    Article  PubMed  CAS  Google Scholar 

  84. Anderson SA, Rader RK, Westlin WF, Null C, Jackson D, Lanza GM, Wickline SA, Kotyk JJ (2000) Magnetic resonance contrast enhancement of neovasculature with alpha(v) beta(3)-targeted nanoparticles. Magn Reson Med 44: 433–439

    Article  PubMed  CAS  Google Scholar 

  85. Schellenberger EA, Sosnovik D, Weissleder R, Josephson L (2004) Magneto/optical annexin V, a multimodal protein. Bioconjug Chem 15: 1062–1067

    Article  PubMed  CAS  Google Scholar 

  86. Bremer C, Tung CH, Weissleder R (2002) Molecular imaging of MMP expression and therapeutic MMP inhibition. Acad Radiol 9,Suppl 2: S314–S315

    PubMed  Google Scholar 

  87. Kanno S, Wu YJ, Lee PC, Dodd SJ, Williams M, Griffith BP, Ho C (2001) Macrophage accumulation associated with rat cardiac allograft rejection detected by magnetic resonance imaging with ultrasmall superparamagnetic iron oxide particles. Circulation 104: 934–938

    PubMed  CAS  Google Scholar 

  88. Mahmood U (2004) Near infrared optical applications in molecular imaging. Earlier, more accurate assessment of disease presence, disease course, and efficacy of disease treatment. IEEE Eng Med Biol Mag 23: 58–66

    Article  PubMed  Google Scholar 

  89. Grimm J, Perez JM, Josephson L, Weissleder R (2004) Novel nanosensors for rapid analysis of telomerase activity. Cancer Res 64: 639–643

    Article  PubMed  CAS  Google Scholar 

  90. Harisinghani MG, Saini S, Weissleder R, Hahn PF, Yantiss RK, Tempany C, Wood BJ, Mueller PR (1999) MR lymphangiography using ultrasmall superparamagnetic iron oxide in patients with primary abdominal and pelvic malignancies: radiographic-pathologic correlation. AJR Am J Roentgenol 172: 1347–1351

    PubMed  CAS  Google Scholar 

  91. Josephson L, Mahmood U, Wunderbaldinger P, Tang Y, Weissleder R (2003) Pan and sentinel lymph node visualization using a near-infrared fluorescent probe. Mol Imaging 2: 18–23

    Article  PubMed  Google Scholar 

  92. Petrovsky A, Schellenberger E, Josephson L, Weissleder R, Bogdanov A Jr. (2003) Near-infrared fluorescent imaging of tumor apoptosis. Cancer Res 63: 1936–1942

    PubMed  CAS  Google Scholar 

  93. Ntziachristos V, Schellenberger EA, Ripoll J, Yessayan D, Graves E, Bogdanov A Jr, Josephson L, Weissleder R (2004) Visualization of antitumor treatment by means of fluorescence molecular tomography with an annexin V-Cy5.5 conjugate. Proc Natl Acad Sci USA 101: 12294–12299

    Article  PubMed  CAS  Google Scholar 

  94. Wunder A, Tung CH, Muller-Ladner U, Weissleder R, Mahmood U (2004) In vivo imaging of protease activity in arthritis: a novel approach for monitoring treatment response. Arthritis Rheum 50: 2459–2465

    Article  PubMed  CAS  Google Scholar 

  95. Denis MC, Mahmood U, Benoist C, Mathis D, Weissleder R (2004) Imaging inflammation of the pancreatic islets in type 1 diabetes. Proc Natl Acad Sci USA 101: 12634–12639

    Article  PubMed  CAS  Google Scholar 

  96. Moore A, Bonner-Weir S, Weissleder R (2001) Noninvasive in vivo measurement of beta-cell mass in mouse model of diabetes. Diabetes 50: 2231–2236

    PubMed  CAS  Google Scholar 

  97. Shah K, Tung CH, Chang CH, Slootweg E, O’Loughlin T, Breakefield XO, Weissleder R (2004) In vivo imaging of HIV protease activity in amplicon vector-transduced gliomas. Cancer Res 64: 273–278

    PubMed  CAS  Google Scholar 

  98. Weissleder R, Cheng HC, Bogdanova A, Bogdanov A Jr (1997) Magnetically labeled cells can be detected by MR imaging. J Magn Reson Imaging 7: 258–263

    PubMed  CAS  Google Scholar 

  99. Hill JM, Dick AJ, Raman VK, Thompson RB, Yu ZX, Hinds KA, Pessanha BS, Guttman MA, Varney TR, Martin BJ et al (2003) Serial cardiac magnetic resonance imaging of injected mesenchymal stem cells. Circulation 108: 1009–1014

    Article  PubMed  Google Scholar 

  100. Kircher MF, Allport JR, Graves EE, Love V, Josephson L, Lichtman AH, Weissleder R (2003) In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumors. Cancer Res 63: 6838–6846

    PubMed  CAS  Google Scholar 

  101. Hogemann D, Josephson L, Weissleder R, Basilion JP (2000) Improvement of MRI probes to allow efficient detection of gene expression. Bioconjug Chem 11: 941–946

    Article  PubMed  CAS  Google Scholar 

  102. Ichikawa T, Hogemann D, Saeki Y, Tyminski E, Terada K, Weissleder R, Chiocca EA, Basilion JP (2002) MRI of transgene expression: correlation to therapeutic gene expression. Neoplasia 4: 523–530

    Article  PubMed  CAS  Google Scholar 

  103. Kircher MF, Josephson L, Weissleder R (2002) Ratio imaging of enzyme activity using dual wavelength optical reporters. Mol Imaging 1: 89–95

    Article  PubMed  CAS  Google Scholar 

  104. Kircher MF, Weissleder R, Josephson L (2004) A dual fluorochrome probe for imaging proteases. Bioconjug Chem 15: 242–248

    Article  PubMed  CAS  Google Scholar 

  105. Wunderbaldinger P, Josephson L, Weissleder R (2002) Crosslinked iron oxides (CLIO): a new platform for the development of targeted MR contrast agents. Acad Radiol 9,Suppl 2: S304–S306

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for Molecular Imaging Research, Massachusetts General Hospital, Harvard Medical School, Fruit Street, Boston, MA, 02114, USA

    David Sosnovik & Ralph Weissleder

Authors
  1. David Sosnovik
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ralph Weissleder
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Institute for Biomedical Engineering, University of ZĂĽrich/ETH ZĂĽrich, Moussonstr. 18, CH - 8092, ZĂĽrich, Switzerland

    Markus Rudin

  2. Novartis International AG, CH-4002, Basel, Switzerland

    Paul L. Herrling

  3. Novartis Institute for Tropical Diseases, 10 Biopolis Road, #05-01 Chromos, Singapore, 138670, Singapore

    Alex Matter M.D. (Director) (Director)

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Birkhäuser Verlag, Basel (Switzerland)

About this chapter

Cite this chapter

Sosnovik, D., Weissleder, R. (2005). Magnetic resonance and fluorescence based molecular imaging technologies. In: Herrling, P.L., Matter, A., Rudin, M. (eds) Imaging in Drug Discovery and Early Clinical Trials. Progress in Drug Research, vol 62. Birkhäuser Basel. https://doi.org/10.1007/3-7643-7426-8_3

Download citation

Publish with us

Policies and ethics

Search

Navigation